SI-BONE Revenue and Competitors
Estimated Revenue & Valuation
- SI-BONE's estimated annual revenue is currently $144.3M per year.
- SI-BONE's estimated revenue per employee is $288,074
- SI-BONE's total funding is $148.1M.
Employee Data
- SI-BONE has 501 Employees.
- SI-BONE grew their employee count by 0% last year.
SI-BONE's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO and Sr. VP Engineering | Reveal Email/Phone |
2 | Sr. VP Clinical and Regulatory Affairs | Reveal Email/Phone |
3 | Area VP Sales-East | Reveal Email/Phone |
4 | VP EMEA Operations | Reveal Email/Phone |
5 | V.P. Medical Affairs | Reveal Email/Phone |
6 | VP, US Sales | Reveal Email/Phone |
7 | VP - US Academic and Commercial Development | Reveal Email/Phone |
8 | VP, Marketing | Reveal Email/Phone |
9 | VP Global Product Management And Business Development | Reveal Email/Phone |
10 | VP Regulatory Affairs | Reveal Email/Phone |
SI-BONE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is SI-BONE?
SI-BONE® is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. SI-BONE developed an innovative, patented implant to fuse the SI joint. The iFuse Implant System® provides a less invasive alternative to traditional sacroiliac (SI) joint fusion surgery and has been used in over 34,000 procedures to date. The company is managed by an experienced team of executives from Kyphon, Medtronic, INBONE, Saint Francis and several start up orthopedic and spine companies. The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks
keywords:N/A
$148.1M
Total Funding
501
Number of Employees
$144.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SI-BONE News
Two analysts have made estimates for SI-BONE's earnings. The highest sales estimate is $22.40 million and the lowest is $22.34 million. SI-BONE...
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment. Published: Apr 19, 2022.
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment. April 19, 2022 08:00 ET | Source: SI-BONE,...
Si-Bone, a San Jose, CA-based sacroiliac joint medical device company, raised $20m in funding. According to a regulatory document filed with the SEC, nine unnamed investors participated in the offering. Led by Jeffrey Dunn, President and Chief Executive Officer, and Mark A. Reiley, MD, Chief M ...
Si-Bone said yesterday that the medical device company raised a $21 million funding round and hired Laura Francis as its new CFO. The round was led by new investor Redline Capital Management and included participation from all existing backers, Si-Bone said. The proceeds are slated to be used t ...
Other Companies in Santa Clara
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $606.9M | 516 | 0% | $57M |
#2 | $47.1M | 520 | 16% | N/A |
#3 | $179.1M | 521 | 3% | N/A |
#4 | $94.6M | 522 | 11% | N/A |
#5 | $120.8M | 537 | N/A | N/A |